In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
Bonifazi
F
F
Bandini
G
G
Stanzani
M
M
Palandri
F
F
Giannini
B
B
Arpinati
M
M
Rosti
G
G
Baccarani
M
M
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008212:Lymphocyte Depletion; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D011446:Prospective Studies
D000961:Antilymphocyte Serum